Skip to content

Clinical trials

Expanded access Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Expanded access Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available5
Approved for marketing2
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Agenus Inc.1
City of Hope Medical Center1
Devalingam Mahalingam1
H. Lee Moffitt Cancer Center and Research Institute1
Leo W. Jenkins Cancer Center1
Ming Zhao1
Replicor Inc.1
University of California, Irvine1
xCures1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular9
Liver Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Melanoma2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Cholangiocarcinoma1
Esophageal Neoplasms1
Esophageal and Gastric Varices1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.